A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors
about
A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Phase II Study of 131I- Meta ...... hromocytoma and Related Tumors
@en
type
label
A Phase II Study of 131I- Meta ...... hromocytoma and Related Tumors
@en
prefLabel
A Phase II Study of 131I- Meta ...... hromocytoma and Related Tumors
@en
P1050
P1476
A Phase II Study of 131I-label ...... hromocytoma and Related Tumors
@en
P3098
NCT01413503
P580
1991-05-01T00:00:00Z
P582
2007-09-06T00:00:00Z